United States Gynandroblastoma Market Size & Outlook, 2026-2034


United States Gynandroblastoma Market Insights

  • As highlighted in Reed Intelligence analysis, the United States Gynandroblastoma Market, worth USD 43.52 Million in 2025, is forecasted to achieve USD 84.72 Million by 2034.
  • The United States market is anticipated to grow at a CAGR of 7.71% during the period 2026–2034.
  • By 2025, Adult-Type Gynandroblastoma represented the largest share of the Type market size.
  • Juvenile-Type Gynandroblastoma is expected to remain the key growth driver within Type, registering the fastest CAGR during the forecast period.

Other Key Findings


  • In 2025, United States represented 30.01% of the overall global Gynandroblastoma Market size.
  • United States is projected to lead the global Gynandroblastoma Market size by 2034.
  • Across North America, United States is anticipated to hold the dominant position in market size by 2034.
  • United States is forecasted to expand at the fastest pace in North America, attaining USD 84.92 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 43.52 Million
Market Size In 2034 USD 84.72 Million
Largest segment Adult-Type Gynandroblastoma
Units Revenue in USD Million
CAGR 7.71% (2026-2034)
Segmnetation Covered
Type
  1. Adult-Type Gynandroblastoma
  2. Juvenile-Type Gynandroblastoma
  3. Mixed-Cell Gynandroblastoma
Treatment
  1. Surgery
  2. Chemotherapy
  3. Targeted Therapy
  4. Radiation Therapy
Diagnosis Method
  1. Histopathology
  2. Imaging Techniques
  3. Molecular Diagnostics
End-Use
  1. Hospitals
  2. Specialty Clinics
  3. Research Institutes
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports